HOME >> MEDICINE >> NEWS
Studies indicate medication can be an effective therapy for smoking cessation

The drug varenicline shows effectiveness in helping smokers quit and abstain from smoking when compared to placebo and the smoking cessation medication bupropion, according to three studies in the July 5 issue of JAMA.

Although nearly 41 percent of smokers try to quit smoking each year, relapse is common, and only about 10 percent achieve and maintain abstinence. The negative effects of nicotine withdrawal account, in part, for low success rates, according to background information in the article. Approved pharmacotherapies to treat nicotine dependence (e.g., nicotine replacement therapy and bupropion) have had important, but moderate efficacy, with reported rates of quitting generally twice those of placebo. Additional and more effective therapies are needed.

David Gonzales, Ph.D., of Oregon Health & Science University, Portland, and colleagues with the Varenicline Phase 3 Study Group evaluated the efficacy of varenicline compared with placebo and sustained-release (SR) bupropion in generally healthy adult smokers. Varenicline is a non-nicotine drug that is thought to be beneficial for smoking cessation by stimulating the release of the chemical dopamine in the brain to reduce craving and withdrawal while simultaneously blocking the reinforcing effects of smoked nicotine. Most other smoking cessation pharmacotherapies are nicotine replacement products.

Participants in the study were 1,025 smokers (10 cigarettes or more per day) with fewer than 3 months of smoking abstinence in the past year. The randomized, double-blind, phase 3 clinical trial was conducted at 19 U.S. centers from June 2003 to April 2005. Participants were randomly assigned to receive brief counseling plus either varenicline twice per day (n = 352), bupropion SR twice per day (n = 329), or placebo (n = 344) orally for 12 weeks, with 40 weeks of nondrug follow-up.

The carbon monoxideconfirmed 4-week continuous abstinence rate for weeks 9 th
'"/>

Contact: Tamara Hargens
503-494-8231
JAMA and Archives Journals
4-Jul-2006


Page: 1 2 3 4 5 6 7

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
9. Studies highlight need to monitor heart function in breast cancer patients
10. Studies examine physician disclosure of medical errors
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
(Date:5/28/2015)... (PRWEB) May 28, 2015 Senior Housing ... legend Lou Piniella, who managed the Seattle Mariners team ... Piniella will appear in television and digital advertising for ... living apartment communities, including several new communities slated to ... Bellevue, Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. ...
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
(Date:5/28/2015)... Jacksonville, Fla. (PRWEB) May 28, 2015 ... center dedicated to patients suffering from acute stroke or ... Emergency Medicine is one of a few in the ... and other neurological emergency needs such as brain aneurysms. ... facilities to take care of patients who are impacted ...
(Date:5/28/2015)... May 28, 2015 ZH Healthcare (ZH), ... that it is releasing BlueEHS, the Electronic Health Solution, ... Image for the benefit of all AWS users worldwide. ... a first of its kind, Freemium, SaaS, Electronic Health ... Records (EHR) with an integrated practice management system (PMS), ...
(Date:5/28/2015)... Edmond, OK (PRWEB) May 28, 2015 ... pain relief lotion and products, today announced their best-selling lotion ... bottle. Real Time Pain Relief is an FDA registered OTC ... natural and herbal ingredients, such as Aloe Vera, Arnica, Capsicum, ... a low level of Menthol – only 1.25% – to ...
Breaking Medicine News(10 mins):Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of the  "North America ... Forecasts (2014 - 2019)"  report to their ... Ultrasound is a type of imaging. ... at body parts and structures inside the ...
(Date:5/28/2015)... May 28, 2015 The Parenteral Drug ... a supporting organization of the Johnson & Johnson ... 2016. Johnson & Johnson (J&J) is ... superbug infections in endoscopes. J&J ran 8 conferences ... 1976 and 2003 on advances in sterilization and ...
(Date:5/28/2015)... Calif. , May 28, 2015  CytomX, a ... cancer, today announced that Sean McCarthy , D. ... Jefferies 2015 Global Healthcare Conference in ... on Tuesday, June 2, 2015. Dr. McCarthy will provide ... Precision cancer immunotherapy and Probody drug conjugate programs. ...
Breaking Medicine Technology:North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
Cached News: